Exclusive: U.S. to make coronavirus strain for possible human challenge trials

Deutschland Nachrichten Nachrichten

Exclusive: U.S. to make coronavirus strain for possible human challenge trials
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 Reuters
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

U.S. government scientists have begun efforts to manufacture a strain of the novel coronavirus that could be used in human challenge trials of vaccines, a controversial type of study in which healthy volunteers would be vaccinated and then intentionally infected with the virus, Reuters has learned.

“Should there be a need for human challenge studies to fully assess candidate vaccines or therapeutics for SARS-CoV-2, NIAID has begun investigations of the technical and ethical considerations of conducting human challenge studies,” the agency statement said.

Such trials are typically done when a virus is not widely circulating, which is not the case with COVID-19. Many scientists consider human challenge trials of the novel coronavirus unethical because there are no “rescue therapies” for those who fall ill. Dr. Anna Durbin, a vaccine researcher at the Johns Hopkins Bloomberg School of Public Health, who has run a dozen challenge studies, estimates it could take nine to 12 months to set up a human challenge trial, and another six months to coordinate testing across multiple testing sites.

“In the setting of a pandemic that is raging, you don’t need it. You just do a trial and get a real result,” he said.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Reuters /  🏆 2. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Novavax to deliver 60 million doses of COVID-19 vaccine candidate to UK for trialNovavax to deliver 60 million doses of COVID-19 vaccine candidate to UK for trialU.S. drug developer Novavax Inc said on Friday the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373, for a phase 3 clinical trial in the country.
Weiterlesen »

Tribune Publishing closes Daily News newsroom in ManhattanTribune Publishing closes Daily News newsroom in ManhattanEconomic strain caused by the coronavirus pandemic also forced the company to shutter the offices of two Maryland newspapers.
Weiterlesen »

No human pyramids in Mumbai's 'Lord Krishna' festival due to coronavirusNo human pyramids in Mumbai's 'Lord Krishna' festival due to coronavirusThere were no human pyramids in Mumbai's Janmashtami festival celebrating Lord Krishna on Wednesday, which normally attracts thousands onto the streets, due to a surge in coronavirus in India, with more than 60,000 cases reported in 24 hours.
Weiterlesen »

Vue In Advanced Talks To Secure $130M Debt Financing Amid Coronavirus ChallengeVue In Advanced Talks To Secure $130M Debt Financing Amid Coronavirus ChallengeCinema chain Vue is close to securing roughly £100M ($130M) in debt financing to help counteract the challenges wrought by coronavirus. Sources confirm to us that there are advanced talks to secure…
Weiterlesen »

What it's like to be in a coronavirus vaccine trialWhat it's like to be in a coronavirus vaccine trialLouis enrolled in the Phase 3 Moderna coronavirus vaccine trial at a site in Las Vegas. Here's what it was like.
Weiterlesen »

Andrew Lloyd Webber 'receiving experimental coronavirus vaccine' as a trialAndrew Lloyd Webber 'receiving experimental coronavirus vaccine' as a trialAndrew Lloyd Webber will be seeing if scientists are playing the right tune with the coronavirus vaccine after volunteering to be part of the trial
Weiterlesen »



Render Time: 2025-03-30 11:15:04